Praxis Precision Medicines, Inc. (PRAX)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Marcio Souza
Employees:
140
101 MAIN STREET, #1210, CAMBRIDGE, MA 02142
617-949-2220

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression.

Data derived from most recent annual or quarterly report
Market Cap 182.502 Million Shares Outstanding45.512 Million Avg 30-day Volume 737.748 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-12.1
Price to Revenue0.0 Debt to Equity0.0 EBITDA-205.952 Million
Price to Book Value2.4295 Operating Margin0.0 Enterprise Value241.581 Million
Current Ratio5.185 EPS Growth-0.904 Quick Ratio4.92
1 Yr BETA 1.3107 52-week High/Low 23.56 / 1.63 Profit Margin0.0
Operating Cash Flow Growth-119.1885 Altman Z-Score1.5678 Free Cash Flow to Firm -119.935 Million
View SEC Filings from PRAX instead.

View recent insider trading info

Funds Holding PRAX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PRAX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-08-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-26:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2022-07-11:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-06-06:
    Item 8.01: Other Events
  • 8-K: filed on 2022-06-01:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-23:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-05-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-29:
    Item 8.01: Other Events
  • 8-K: filed on 2022-04-27:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    10.5 Thousand total shares from 2 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SOUZA MARCIO CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    100,000 2022-06-22 5

    RAVINA BERNARD CHIEF MEDICAL OFFICER

    • Officer
    65,000 2022-06-22 3

    SWEENY NICOLE CHIEF COMMERCIAL OFFICER

    • Officer
    65,000 2022-06-22 4

    MASTROCOLA LAUREN PRINCIPAL ACCOUNTING OFFICER

    • Officer
    16,000 2022-06-22 5

    NEMIROFF ALEX GENERAL COUNSEL AND SECRETARY

    • Officer
    65,000 2022-06-22 5

    KELLY TIMOTHY EDWIN CHIEF FINANCIAL OFFICER

    • Officer
    65,000 2022-06-22 5

    MITCHELL DEAN J

    • Director
    25,000 2022-06-08 2

    YOUNG WILLIAM D

    • Director
    22,753 2022-05-26 1

    NORDEN GREGORY

    • Director
    22,753 2022-05-26 1

    CHODAKEWITZ JEFFREY

    • Director
    22,753 2022-05-26 1

    VITOROVIC STEFAN

    • Director
    22,753 2022-05-26 1

    CUDKOWICZ MERIT ESTER

    • Director
    22,753 2022-05-26 1

    DESIMONE JILL

    • Director
    0 2022-05-23 2

    BSOF PARALLEL MASTER FUND L.P.

    BLACKSTONE STRATEGIC OPPORTUNITY ASSOCIATES L.L.C.

    BLACKSTONE ALTERNATIVE SOLUTIONS L.L.C.

    BLACKSTONE HOLDINGS I L.P.

    BLACKSTONE HOLDINGS II L.P.

    BLACKSTONE HOLDINGS I/II GP L.L.C.

    BLACKSTONE INC

    BLACKSTONE GROUP MANAGEMENT L.L.C.

    SCHWARZMAN STEPHEN A

    • 10% Owner
    4,894,109 2021-10-06 5

    CLARUS LIFESCIENCES III, L.P.

    CLARUS VENTURES III GP, L.P.

    • 10% Owner
    5,801,487 2021-05-12 0

    CLARUS LIFESCIENCES III, L.P.

    CLARUS VENTURES III GP, L.P.

    BLACKSTONE CLARUS III L.L.C.

    BLACKSTONE HOLDINGS I L.P.

    BLACKSTONE HOLDINGS II L.P.

    BLACKSTONE HOLDINGS I/II GP L.L.C.

    BLACKSTONE GROUP INC

    BLACKSTONE GROUP MANAGEMENT L.L.C.

    SCHWARZMAN STEPHEN A

    • 10% Owner
    8,501,487 2020-10-20 0

    NOVO HOLDINGS A/S

    • 10% Owner
    No longer subject to file 2020-10-20 0

    BSOF PARALLEL MASTER FUND L.P.

    BLACKSTONE STRATEGIC OPPORTUNITY ASSOCIATES L.L.C.

    BLACKSTONE ALTERNATIVE SOLUTIONS L.L.C.

    • 10% Owner
    8,501,487 2020-10-20 0

    GALAKATOS NICHOLAS

    • Director
    0 2020-10-15 0

    REDDY KIRAN

    • Director
    467,289 2020-10-15 0

    CHAFFEE STUART CHIEF FINANCIAL OFFICER

    • Officer
    0 2020-10-15 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    KELLY TIMOTHY EDWIN - Officer CHIEF FINANCIAL OFFICER

    2022-06-24 16:46:06 -0400 2022-06-22 A 65,000 a 65,000 direct

    SOUZA MARCIO - Director - Officer CHIEF EXECUTIVE OFFICER

    2022-06-24 16:45:18 -0400 2022-06-22 A 100,000 a 100,000 direct

    RAVINA BERNARD - Officer CHIEF MEDICAL OFFICER

    2022-06-24 16:47:04 -0400 2022-06-22 A 65,000 a 65,000 direct

    SWEENY NICOLE - Officer CHIEF COMMERCIAL OFFICER

    2022-06-24 16:50:30 -0400 2022-06-22 A 65,000 a 65,000 direct

    NEMIROFF ALEX - Officer GENERAL COUNSEL AND SECRETARY

    2022-06-24 16:48:57 -0400 2022-06-22 A 65,000 a 65,000 direct

    MASTROCOLA LAUREN - Officer PRINCIPAL ACCOUNTING OFFICER

    2022-06-24 16:52:28 -0400 2022-06-22 A 16,000 a 16,000 direct

    MASTROCOLA LAUREN - Officer PRINCIPAL ACCOUNTING OFFICER

    2022-06-21 16:35:45 -0400 2022-06-16 P 3,000 $1.93 a 31,391 direct 10.3774 18.3962 56.1321 68.8679 17 0.0 1

    NEMIROFF ALEX - Officer GENERAL COUNSEL AND SECRETARY

    2022-06-14 19:56:24 -0400 2022-06-13 P 7,500 $1.63 a 39,347 direct 0.5181 21.2435 82.9016 85.4922 21 0.0 1

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    PRAXIS PRECISION MEDICINES I PRAX 2022-08-10 21:45:04 UTC 1.695 0.625 850000
    PRAXIS PRECISION MEDICINES I PRAX 2022-08-10 21:15:05 UTC 1.695 0.625 850000
    PRAXIS PRECISION MEDICINES I PRAX 2022-08-10 20:45:04 UTC 1.695 0.625 850000
    PRAXIS PRECISION MEDICINES I PRAX 2022-08-10 20:15:06 UTC 1.695 0.625 850000
    PRAXIS PRECISION MEDICINES I PRAX 2022-08-10 19:45:04 UTC 1.695 0.625 850000
    PRAXIS PRECISION MEDICINES I PRAX 2022-08-10 19:15:05 UTC 1.695 0.625 850000
    PRAXIS PRECISION MEDICINES I PRAX 2022-08-10 18:45:04 UTC 1.695 0.625 850000
    PRAXIS PRECISION MEDICINES I PRAX 2022-08-10 18:15:04 UTC 1.695 0.625 850000
    PRAXIS PRECISION MEDICINES I PRAX 2022-08-10 17:45:04 UTC 1.695 0.625 850000
    PRAXIS PRECISION MEDICINES I PRAX 2022-08-10 17:15:04 UTC 1.695 0.625 850000
    PRAXIS PRECISION MEDICINES I PRAX 2022-08-10 16:45:04 UTC 1.7957 0.5243 850000
    PRAXIS PRECISION MEDICINES I PRAX 2022-08-10 16:15:03 UTC 1.7957 0.5243 850000
    PRAXIS PRECISION MEDICINES I PRAX 2022-08-10 15:45:05 UTC 1.7957 0.5243 850000
    PRAXIS PRECISION MEDICINES I PRAX 2022-08-10 15:15:05 UTC 1.7957 0.5243 850000
    PRAXIS PRECISION MEDICINES I PRAX 2022-08-10 14:45:04 UTC 1.7957 0.5243 850000
    PRAXIS PRECISION MEDICINES I PRAX 2022-08-10 14:15:03 UTC 1.7957 0.5243 850000
    PRAXIS PRECISION MEDICINES I PRAX 2022-08-10 13:45:03 UTC 1.7957 0.5243 850000
    PRAXIS PRECISION MEDICINES I PRAX 2022-08-10 13:15:04 UTC 1.7957 0.5243 850000
    PRAXIS PRECISION MEDICINES I PRAX 2022-08-10 12:45:05 UTC 1.7957 0.5243 850000
    PRAXIS PRECISION MEDICINES I PRAX 2022-08-09 22:15:07 UTC 1.7957 0.5243 800000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund PRAX -1036.0 shares, $-8391.6 2022-04-30 N-PORT
    Weiss Strategic Interval Fund- Weiss Strategic Interval Fund PRAX -3494.0 shares, $-35673.74 2022-03-31 N-PORT

    Elevate your investments